Zobrazeno 1 - 10 of 88 pro vyhledávání: '"Ac, Rios"'
2
[Epidemiologic analysis of genital diseases associated to papillomavirus]
Autor: Ac, Rios, silvia cavalcanti, Dm, Menezes, Lh, Oliveira
Publikováno v: Europe PubMed Central
In order to investigate genital papillomavirus infection in a university hospital, we verified that condyloma acuminata and epidermoid carcinoma were the most common diseases associated to this virus.This study was undertaken to verify the prevalence
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::717c1acdfa565d09f5d17115dba9bf93
http://europepmc.org/abstract/med/8731597
Zobrazit plný text záznamu
3
Akademický článek
Human breast tissue engineering in health and disease.
Autor: Buchholz MB; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Scheerman DI; Department of Clinical Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands., Levato R; Department of Clinical Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands.; Department of Orthopedics, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Wehrens EJ; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Rios AC; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands. a.c.rios@prinsesmaximacentrum.nl.; Oncode Institute, Utrecht, The Netherlands. a.c.rios@prinsesmaximacentrum.nl.
Publikováno v: EMBO molecular medicine [EMBO Mol Med] 2024 Oct; Vol. 16 (10), pp. 2299-2321. Date of Electronic Publication: 2024 Aug 23.
Zobrazit plný text záznamu
4
Akademický článek
Single-cell RNA sequencing of pediatric Hodgkin lymphoma to study the inhibition of T cell subtypes.
Autor: de Kanter JK; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands.; Oncode Institute Utrecht The Netherlands., Steemers AS; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands.; Oncode Institute Utrecht The Netherlands., Gonzalez DM; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands.; Oncode Institute Utrecht The Netherlands., van Ineveld RL; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands.; Oncode Institute Utrecht The Netherlands., Blijleven C; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands.; Oncode Institute Utrecht The Netherlands.; Present address: University of Copenhagen Copenhagen Denmark., Groenen N; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands.; Oncode Institute Utrecht The Netherlands., Trabut L; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands.; Oncode Institute Utrecht The Netherlands., Scheijde-Vermeulen MA; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands., Westera L; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands., Beishuizen A; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands., Rios AC; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands.; Oncode Institute Utrecht The Netherlands., Holstege FCP; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands., Brandsma AM; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands.; Oncode Institute Utrecht The Netherlands.; Present address: Sanquin Blood Bank Amsterdam the Netherlands., Margaritis T; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands., van Boxtel R; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands.; Oncode Institute Utrecht The Netherlands., Meyer-Wentrup F; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands.
Publikováno v: HemaSphere [Hemasphere] 2024 Sep 02; Vol. 8 (9), pp. e149. Date of Electronic Publication: 2024 Sep 02 (Print Publication: 2024).
Zobrazit plný text záznamu
5
Akademický článek
BEHAV3D: a 3D live imaging platform for comprehensive analysis of engineered T cell behavior and tumor response.
Autor: Alieva M; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands. malieva@iib.uam.es.; Instituto de Investigaciones Biomédicas Sols-Morreale (IIBM), CSIC-UAM, Madrid, Spain. malieva@iib.uam.es., Barrera Román M; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., de Blank S; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Petcu D; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Zeeman AL; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Dautzenberg NMM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Cornel AM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Center for Translational Immunology, University Medical Centre (UMC) Utrecht, Utrecht, the Netherlands., van de Ven C; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Pieters R; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., den Boer ML; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Nierkens S; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Center for Translational Immunology, University Medical Centre (UMC) Utrecht, Utrecht, the Netherlands., Calkoen FGJ; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Clevers H; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and UMC Utrecht, Utrecht, the Netherlands.; Pharma, Research and Early Development (pRED), F. Hoffmann-La Roche Ltd, Basel, Switzerland., Kuball J; Center for Translational Immunology, University Medical Centre (UMC) Utrecht, Utrecht, the Netherlands.; Department of Hematology, UMC Utrecht, Utrecht University, Utrecht, the Netherlands., Sebestyén Z; Center for Translational Immunology, University Medical Centre (UMC) Utrecht, Utrecht, the Netherlands., Wehrens EJ; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Dekkers JF; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Rios AC; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands. a.c.rios@prinsesmaximacentrum.nl.; Oncode Institute, Utrecht, the Netherlands. a.c.rios@prinsesmaximacentrum.nl.
Publikováno v: Nature protocols [Nat Protoc] 2024 Jul; Vol. 19 (7), pp. 2052-2084. Date of Electronic Publication: 2024 Mar 19.
Zobrazit plný text záznamu
6
Akademický článek
A multispectral 3D live organoid imaging platform to screen probes for fluorescence guided surgery.
Autor: Jeremiasse B; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., van Ineveld RL; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Bok V; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Kleinnijenhuis M; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., de Blank S; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Alieva M; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Instituto de Investigaciones Biomedicas Sols-Morreale (IIBM), CSIC-UAM, Madrid, Spain., Johnson HR; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., van Vliet EJ; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Zeeman AL; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Wellens LM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Llibre-Palomar G; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Barrera Román M; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Di Maggio A; Pharmaceutics, Department of Pharmaceutical Sciences, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, 3584 CG, Utrecht, The Netherlands.; Cell Biology, Neurobiology and Biophysics, Department of Biology, Science Faculty, Utrecht University, 3584 CH, Utrecht, The Netherlands., Dekkers JF; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Oliveira S; Pharmaceutics, Department of Pharmaceutical Sciences, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, 3584 CG, Utrecht, The Netherlands.; Cell Biology, Neurobiology and Biophysics, Department of Biology, Science Faculty, Utrecht University, 3584 CH, Utrecht, The Netherlands., Vahrmeijer AL; Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands., Molenaar JJ; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Wijnen MH; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., van der Steeg AF; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Wehrens EJ; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Rios AC; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands. a.c.rios@prinsesmaximacentrum.nl.; Oncode Institute, Utrecht, The Netherlands. a.c.rios@prinsesmaximacentrum.nl.
Publikováno v: EMBO molecular medicine [EMBO Mol Med] 2024 Jul; Vol. 16 (7), pp. 1495-1514. Date of Electronic Publication: 2024 Jun 03.
Zobrazit plný text záznamu
7
Akademický článek
The Virtual Child.
Autor: Gilbertson RJ; CRUK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.; Department of Oncology, University of Cambridge, Cambridge, United Kingdom., Behjati S; Wellcome Sanger Institute, Hinxton, United Kingdom.; Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.; Department of Paediatrics, University of Cambridge, Cambridge, United Kingdom., Böttcher AL; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany., Bronner ME; Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, California., Burridge M; Amazon Web Services, London, United Kingdom., Clausing H; SELECT SouthWest, Germany., Clifford H; NVIDIA, Cambridge, United Kingdom., Danaher T; Children's Cancer Foundation, Australia., Donovan LK; University College London Great Ormond Street Institute of Child Health, United Kingdom., Drost J; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Eggermont AMM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Emerson C; NVIDIA, Cambridge, United Kingdom., Flores MG; NVIDIA, Santa Clara, California., Hamerlik P; University of Manchester, Manchester, United Kingdom., Jabado N; Department of Paediatrics, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada., Jones A; Amazon Web Services, London, United Kingdom., Kaessmann H; Center for Molecular Biology of Heidelberg University (ZMBH), Heidelberg, Germany., Kleinman CL; Lady Davis Research Institute, Jewish General Hospital, Montreal, Quebec, Canada.; Department of Human Genetics, McGill University, Montreal, Quebec, Canada., Kool M; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Kutscher LM; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; Developmental Origins of Pediatric Cancer Junior Research Group, German Cancer Research Center (DKFZ), Heidelberg, Germany., Lindberg G; The EVAN Foundation, Maryland., Linnane E; CRUK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.; Department of Oncology, University of Cambridge, Cambridge, United Kingdom., Marioni JC; CRUK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.; Wellcome Sanger Institute, Hinxton, United Kingdom.; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Cambridge, United Kingdom., Maris JM; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.; Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania., Monje M; Department of Neurology and Neurological Sciences, Stanford University, Stanford, California., Macaskill A; AstraZeneca, Oncology R&D, Cambridge, United Kingdom., Niederer S; Turing Research and Innovation Cluster in Digital Twins (TRIC: DT), The Alan Turing Institute, London, United Kingdom., Northcott PA; Department of Developmental Neurobiology, St Jude Children's Research Hospital, Memphis, Tennessee., Peeters E; b.r.a.i.n.child, SickKids Hospital, Toronto, Ontario, Canada., Plieger-van Solkema W; Dutch Childhood Cancer Organization (VKKN), the Netherlands., Preußner L; BioNTech SE, Mainz, Germany., Rios AC; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Rippe K; German Cancer Research Center (DKFZ) Heidelberg, Division of Chromatin Networks, Heidelberg, Germany., Sandford P; Amazon Web Services, London, United Kingdom., Sgourakis NG; Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.; Department of Pathology and Lab Medicine, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania., Shlien A; Genetics and Genomics Program, The Hospital for Sick Children, Toronto, Canada., Smith P; Hula Therapeutics, Philadelphia, Pennsylvania., Straathof K; University College London Cancer Institute, London, United Kingdom.; Great Ormond Street Hospital for Children, London, United Kingdom., Sullivan PJ; Team Finn Foundation, Vancouver, British Columbia, Canada., Suvà ML; Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.; Broad Institute of MIT and Harvard, Boston, Massachusetts., Taylor MD; Texas Children's Cancer Center, Hematology-Oncology Section and Department of Pediatrics - Hematology/Oncology and Neurosurgery, Baylor College of Medicine, Houston, Texas., Thompson E; Brain Tumour Charity, Fleet, United Kingdom., Vento-Tormo R; Wellcome Sanger Institute, Hinxton, United Kingdom., Wainwright BJ; The University of Queensland Frazer Institute, Translational Research Institute, Woolloongabba, Queensland, Australia., Wechsler-Reya RJ; Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York., Westermann F; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; Division of Neuroblastoma Genomics, German Cancer Research Center (DKFZ), Heidelberg, Germany., Winslade S; Brain Tumour Charity, Fleet, United Kingdom., Al-Lazikani B; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Pfister SM; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.
Publikováno v: Cancer discovery [Cancer Discov] 2024 Apr 04; Vol. 14 (4), pp. 663-668.
Zobrazit plný text záznamu
8
Akademický článek
Intraparenchymal pericatheter cyst: a rare but important manifestation of cerebrospinal shunt failure.
Autor: Marques D; Neuroradiology Department, Hospital Garcia de Orta, Almada, Portugal. diogomarques1993@gmail.com., Castelão F; Neuroradiology Department, Hospital Garcia de Orta, Almada, Portugal., Silva RP; Neuroradiology Department, Hospital Garcia de Orta, Almada, Portugal., Rios AC; Neuroradiology Department, Hospital Garcia de Orta, Almada, Portugal.
Publikováno v: Neurologia i neurochirurgia polska [Neurol Neurochir Pol] 2024; Vol. 58 (1), pp. 136-138. Date of Electronic Publication: 2024 Feb 12.
Zobrazit plný text záznamu
9
Akademický článek
Bridging live-cell imaging and next-generation cancer treatment.
Autor: Alieva M; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Instituto de Investigaciones Biomedicas Sols-Morreale (IIBM), CSIC-UAM, Madrid, Spain., Wezenaar AKL; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Wehrens EJ; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands. e.j.m.wehrens-4@prinsesmaximacentrum.nl.; Oncode Institute, Utrecht, The Netherlands. e.j.m.wehrens-4@prinsesmaximacentrum.nl., Rios AC; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands. a.c.rios@prinsesmaximacentrum.nl.; Oncode Institute, Utrecht, The Netherlands. a.c.rios@prinsesmaximacentrum.nl.
Publikováno v: Nature reviews. Cancer [Nat Rev Cancer] 2023 Nov; Vol. 23 (11), pp. 731-745. Date of Electronic Publication: 2023 Sep 13.
Zobrazit plný text záznamu
10
Akademický článek
CRISPR screens decode cancer cell pathways that trigger γδ T cell detection.
Autor: Mamedov MR; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA. murad.mamedov@ucsf.edu.; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA. murad.mamedov@ucsf.edu., Vedova S; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA.; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Freimer JW; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA.; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Department of Genetics, Stanford University, Stanford, CA, USA., Sahu AD; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA.; UNM Comprehensive Cancer Center, University of New Mexico, Albuquerque, NM, USA., Ramesh A; Department of Biochemistry and Molecular Biology, University of Chicago, Chicago, IL, USA., Arce MM; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA.; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Meringa AD; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, the Netherlands., Ota M; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA.; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Department of Genetics, Stanford University, Stanford, CA, USA., Chen PA; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA.; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Hanspers K; Institute of Data Science and Biotechnology, Gladstone Institutes, San Francisco, CA, USA., Nguyen VQ; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA.; Department of Surgery, University of California, San Francisco, San Francisco, CA, USA.; Diabetes Center, University of California, San Francisco, San Francisco, CA, USA.; UCSF CoLabs, University of California, San Francisco, San Francisco, CA, USA., Takeshima KA; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA., Rios AC; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Pritchard JK; Department of Genetics, Stanford University, Stanford, CA, USA.; Department of Biology, Stanford University, Stanford, CA, USA., Kuball J; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, the Netherlands.; Department of Hematology, University Medical Center Utrecht, Utrecht, the Netherlands., Sebestyen Z; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, the Netherlands., Adams EJ; Department of Biochemistry and Molecular Biology, University of Chicago, Chicago, IL, USA.; Committee on Immunology, University of Chicago, Chicago, IL, USA., Marson A; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA. alexander.marson@ucsf.edu.; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA. alexander.marson@ucsf.edu.; Diabetes Center, University of California, San Francisco, San Francisco, CA, USA. alexander.marson@ucsf.edu.; Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA, USA. alexander.marson@ucsf.edu.; Innovative Genomics Institute, University of California-Berkeley, Berkeley, CA, USA. alexander.marson@ucsf.edu.; UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA. alexander.marson@ucsf.edu.; Parker Institute for Cancer Immunotherapy, University of California, San Francisco, San Francisco, CA, USA. alexander.marson@ucsf.edu.; Institute for Human Genetics, University of California, San Francisco, San Francisco, CA, USA. alexander.marson@ucsf.edu.
Publikováno v: Nature [Nature] 2023 Sep; Vol. 621 (7977), pp. 188-195. Date of Electronic Publication: 2023 Aug 30.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje